In the synthetic cohort, 45 of 200 participants who received a
medication review and 112 of 512 who did not receive one had
activity-limiting disability at six months. The crude risk ratio was
1.03 (95% CI 0.76 to 1.40). After adjustment for age, baseline frailty,
sex, living alone, deprivation, medication count and baseline disability,
the disability odds ratio was 0.64 (95% CI 0.41 to 1.01).
The adjusted six-month EQ-5D-style mean difference was +0.047 (95% CI
0.034 to 0.059). Because review allocation was observational and the
data are simulated, these estimates illustrate confounding and model
interpretation; they are not clinical-effect estimates.
Representative output · same teaching data in all three routes
Primary worked findings
Crude disability risk ratio 1.03 (95% CI 0.76 to 1.40)
Adjusted disability odds ratio 0.64 (95% CI 0.41 to 1.01)
Adjusted quality-of-life difference +0.047 (95% CI 0.034 to 0.059)
Adjusted frailty common odds ratio 0.43 (95% CI 0.28 to 0.66)
Adjusted falls incidence-rate ratio 0.79 (95% CI 0.63 to 0.98)
Adjusted admission hazard ratio 0.70 (95% CI 0.47 to 1.07)
What the output means
These estimates answer different questions and cannot be compared as if they were on one scale. Risk ratios compare probabilities, odds ratios compare odds, the mean difference remains in quality-of-life points, the incidence-rate ratio compares fall rates and the hazard ratio compares instantaneous admission hazards. All adjusted estimates remain observational cohort associations.
Write the interpretation like this
Medication review was associated with higher adjusted mean quality of life, lower odds of worse frailty and a lower fall rate at six months. Estimates for disability odds and admission hazard were imprecise and compatible with no association. Because review was not randomised, the findings should not be interpreted as causal effects.
Include the event definition, time horizon, reference group,
covariates, effect scale and confidence interval. “Significant” or
“not significant” is not a results paragraph.